title: Anticoagulation versus aspirin for geriatric patients with atrial fibrillation: is there still any doubt?
authors.forename: Aline
authors.initials: A
authors.lastname: Corvol
authors.forename: Cécile
authors.initials: C
authors.lastname: Legendre
authors.forename: Coralie
authors.initials: C
authors.lastname: Jean
authors.forename: Hayat
authors.initials: H
authors.lastname: Lahjibi-Paulet
authors.forename: Olivier
authors.initials: O
authors.lastname: Saint-Jean
authors.forename: Dominique
authors.initials: D
authors.lastname: Somme
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005060:Europe; D016330:Frail Elderly; D006801:Humans; D009656:North America; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results
chemical_list: D000925:Anticoagulants; D001241:Aspirin